MAHON PAUL A, EVP, GC, reported an open-market or private sale at UNITED THERAPEUTICS Corp involving 477.000000 shares for an estimated $229398.41. Reported holdings after the transaction were 44604.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
Form 4 relationship flags and nearby filing context
EVP & GENERAL COUNSEL
This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.
This transaction was executed in multiple trades at prices ranging from $480.21 to $481.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
This transaction was executed in multiple trades at prices ranging from $481.29 to $482.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
This transaction was executed in multiple trades at prices ranging from $482.29 to $483.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
This transaction was executed in multiple trades at prices ranging from $483.32 to $484.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
This transaction was executed in multiple trades at prices ranging from $484.32 to $485.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
This transaction was executed in multiple trades at prices ranging from $485.34 to $485.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
0 other filings
0 recent txs